Otolaryngology Doctors in Pennsylvania Medicare Details, Address, Contact

584 Otolaryngology doctors found. Showing 121 - 140

Dr. Jack Bryant Anon, M.D. Otolaryngology - Otolaryngic Allergy Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, Erie, PA 16505 Phone: 814-864-9994    Fax: 814-866-2655

Dr. Stephen Eugene Schell, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, Erie, PA 16505 Phone: 814-864-9994    Fax: 814-866-2655

Dr. Sean Thomas Carroll, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 E Bayfront Pkwy Ste 3, Erie, PA 16507 Phone: 814-877-9060    Fax: 814-877-9089

Rick Fornelli, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 380 E Bayfront Pkwy Ste 3, Erie, PA 16507 Phone: 814-877-9060    Fax: 814-877-9089

Robert Guelcher, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 521 Montmarc Blvd, Erie, PA 16504 Phone: 814-825-7954

Dr. Sidney Philip Lipman, M.D. Otolaryngology - Otolaryngic Allergy Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, #200, Erie, PA 16505 Phone: 814-864-9994    Fax: 814-866-2655

Dr. Kirk William Steehler, D.O. Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, Erie, PA 16505 Phone: 814-864-9994    Fax: 814-866-2655

Dr. Ruthann I Lipman, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1645 W 8th St, #106, Erie, PA 16505 Phone: 814-864-9994    Fax: 814-866-2655

Dr. Elliott Jody Bilofsky, DO Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 202 Memorial Drive, Suite 1, Everett, PA 15537 Phone: 814-623-6400    Fax: 814-623-1963

Dr. Joseph L Smith Ii, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532    Fax: 610-363-0210

Dr. Adam J Mariotti, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532    Fax: 610-363-0210

Dr. Andrew V Chuma, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 460 Creamery Way, Suite 103, Exton, PA 19341 Phone: 610-384-8300    Fax: 610-384-8885

Jillian Mattioni, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 460 Creamery Way Ste 103, Exton, PA 19341 Phone: 610-384-8300    Fax: 610-384-8885

Dr. Michael A. Picariello, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532    Fax: 610-363-0210

Dr. Alexander C. Keszeli, D.O. Otolaryngology - Otolaryngic Allergy Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532    Fax: 610-363-0210

Dr. Michael A. Hoffmann, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 460 Creamery Way, Exton, PA 19341 Phone: 610-384-8300

Dr. Ibrahim Toufic Bawab, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 124 Home Depot Dr, Franklin, PA 16323 Phone: 814-657-8739

Dr. Pamela A Crawford, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1029 Liberty St, Franklin, PA 16323 Phone: 814-437-7266    Fax: 814-437-7148

Dr. Kathleen A Fitch, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1029 Liberty St, Franklin, PA 16323 Phone: 814-437-7266    Fax: 814-437-7148

Dr. Matthew David Blum, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1218 Dillon Road, Ft. Washington, PA 19034 Phone: 215-851-9700    Fax: 215-851-9701

News Archive

Merz Pharma Group granted early termination in connection with BioForm Medical share tender offer

Merz Pharma Group today announced that it has been granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, by the U.S. Federal Trade Commission and the U.S. Department of Justice in connection with the previously announced US$5.45 per share cash tender offer made by Merz GmbH & Co. KGaA ("Merz") and its acquisition subsidiary to purchase all outstanding shares of common stock of BioForm Medical, Inc..

SurModics to sell Pharma assets to Evonik for $30 million

SurModics, Inc., a leading provider of surface modification technologies to the healthcare industry, announced today that it has entered into a definitive agreement to sell its SurModics Pharmaceuticals assets to Evonik Industries AG for $30 million in cash.

Agreement on voluntary land guidelines shows collaboration on food security is possible

"The endorsement of voluntary guidelines to improve the way countries govern access rights to land, fisheries and forest resources by the Committee on World Food Security (CFS) on Friday marks a historic milestone not only for the way in which land tenure is managed, but also for international consensus-building," Jose Graziano da Silva, director-general of the U.N.'s Food and Agriculture Organization (FAO), writes in this post in the Guardian's "Poverty Matters" blog.

Public Health Advisory for medical professionals with patients on anti-depression medication

On Monday, March 22, 2004 the Food and Drug Administration issued a Public Health Advisory for medical professionals to monitor for signs of suicidal ideation in individuals who have recently started taking anti-depression medication or have had a recent change in dosage, especially for children who are taking these medications. Antidepressant medications involved in this warning include: Prozac (Fluoxetine), Zoloft, Paxil, Luvox, Celexa, Lexapro, Wellbutrin, Effexor,, Serzone, and Remeron.

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for treatment of GBM

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.

Read more Medical News

› Verified 4 days ago

• «
• 2
• 3
• 4
• 5
• 6
• 7(current)
• 8
• 9
• 10
• 11
• 12
• »